Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Melanoma is the third most common type of skin cancer, characterized by its heterogeneity and propensity to metastasize to distant organs. Melanoma is a heterogeneous tumor, composed of genetically divergent subpopulations, including a small fraction of melanoma-initiating cancer stem-like cells (CS...
Main Authors: | Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, Thomas W. Flanagan, Abdulhadi A. Alamodi, Sofie-Yasmin Hassan, Hosam Shalaby, Sarah-Lilly Hassan, Youssef Haikel, Mosaad Megahed, Simeon Santourlidis, Mohamed Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/2/470 |
Similar Items
-
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance
by: Naji Kharouf, et al.
Published: (2024-01-01) -
Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
by: Naji Kharouf, et al.
Published: (2023-06-01) -
Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways
by: Denis Selimovic, et al.
Published: (2023-03-01) -
Targeted Therapy in Melanoma and Mechanisms of Resistance
by: Anna M. Czarnecka, et al.
Published: (2020-06-01) -
New Approaches to Targeted Therapy in Melanoma
by: Manuel Felipe Fernandez, et al.
Published: (2023-06-01)